Found: 27
Select item for more details and to access through your institution.
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01783-6
- By:
- Publication type:
- Article
Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 4, p. 333, doi. 10.1111/head.14692
- By:
- Publication type:
- Article
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01736-z
- By:
- Publication type:
- Article
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024241235156
- By:
- Publication type:
- Article
Risk factors for migraine disease progression: a narrative review for a patient-centered approach.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 12, p. 5692, doi. 10.1007/s00415-023-11880-2
- By:
- Publication type:
- Article
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01636-8
- By:
- Publication type:
- Article
The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review.
- Published in:
- Pain & Therapy, 2023, v. 12, n. 3, p. 655, doi. 10.1007/s40122-023-00501-5
- By:
- Publication type:
- Article
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 420, doi. 10.1111/head.14266
- By:
- Publication type:
- Article
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01351-2
- By:
- Publication type:
- Article
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01249-z
- By:
- Publication type:
- Article
Biomarkers in Migraine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Unusual Brain MRI Findings in Patients Imaged for Headache: a Case Series.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 859, doi. 10.2147/JPR.S203650
- By:
- Publication type:
- Article
Correction to: Diving Headache.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diving Headache.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nummular Headache.
- Published in:
- Current Neurology & Neuroscience Reports, 2019, v. 19, n. 6, p. 1, doi. 10.1007/s11910-019-0943-x
- By:
- Publication type:
- Article
The Neuralgias.
- Published in:
- Current Neurology & Neuroscience Reports, 2018, v. 18, n. 10, p. 1, doi. 10.1007/s11910-018-0880-0
- By:
- Publication type:
- Article
Exploding Head Syndrome: a Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bath-Related Headache.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ketamine Infusions for Treatment Refractory Headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 2, p. 276, doi. 10.1111/head.13013
- By:
- Publication type:
- Article
CADASIL: Imaging Characteristics and Clinical Correlation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Acute Tension-Type Headaches Are Associated with Impaired Cognitive Function and More Negative Mood.
- Published in:
- Frontiers in Neurology, 2016, p. 1, doi. 10.3389/fneur.2016.00042
- By:
- Publication type:
- Article
Chemical Mediators of Migraine: Preclinical and Clinical Observations.
- Published in:
- Headache: The Journal of Head & Face Pain, 2011, v. 51, n. 6, p. 1029, doi. 10.1111/j.1526-4610.2011.01929.x
- By:
- Publication type:
- Article
Medication adaptation headache.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Triptans: Actions and Reactions.
- Published in:
- Headache: The Journal of Head & Face Pain, 2008, v. 48, n. 4, p. 611, doi. 10.1111/j.1526-4610.2008.01077.x
- By:
- Publication type:
- Article